Dr. Satheesh C. T

Dr. Satheesh is a highly experienced Medical Oncologist and Hemato-Oncologist serving as the Director of Clinical Trials at HCG Cancer Centre, Bengaluru. He specializes in the comprehensive management of solid tumors and hematological malignancies through advanced systemic cancer therapies, including chemotherapy, immunotherapy, targeted therapy, and precision medicine.

Dr. Satheesh has a special interest in cancer genomics and personalized oncology, enabling customized treatment plans based on each patient's genetic profile. He is also trained in palliative care and is committed to delivering compassionate, patient-centered cancer care while actively contributing to clinical research and innovation.

Expertise

• Medical Oncology.
• Hemato-Oncology.
• Treatment of Solid Tumors.
• Management of Hematological Malignancies.
• Conventional Chemotherapy.
• High-Dose Chemotherapy.
• Targeted Therapy.
• Immunotherapy.
• Pediatric Cancers.
• Lymphoma.
• Breast Cancer.
• Lung Cancer.
• Gynecological Cancers.
• Cancer Genomics and Precision Medicine.
• Bone Marrow Aspiration and Biopsy.
• Autologous Stem Cell Transplantation.
• Central Venous Line Insertion.
• Lumbar Puncture.
• Intraperitoneal Chemotherapy.
• Palliative Care.

Training & Certifications

• Advanced Training in the Essentials of Palliative Care – Indian Association of Palliative Care (IAPC).
• Clinical Placement Training in Palliative Care – Indian Association of Palliative Care (IAPC).

Leadership & Recognition

• Director of Clinical Trials at HCG Cancer Centre, Bengaluru.
• Actively involved in multiple national and international oncology clinical trials.
• Author and co-author of more than 50 peer-reviewed national and international scientific publications.
• Special interest in cancer genomics, precision oncology, and personalized medicine.

Research & Publications

Dr. Satheesh has made significant contributions to cancer research through more than 50 scientific publications in reputed national and international journals. His research focuses on breast cancer, lung cancer, precision oncology, cancer genomics, immunotherapy, targeted therapy, biomarkers, thyroid cancer, intraperitoneal chemotherapy, and personalized cancer treatment. As the Director of Clinical Trials, he continues to lead and participate in clinical research aimed at improving cancer diagnosis, treatment, and patient outcomes.